Trials / Completed
CompletedNCT03187457
PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Danisco · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study will assess vaginal microbiota levels before and after antibiotic treatment in females infected with Bacterial Vaginosis (BV).
Detailed description
This method validation study will endeavour to obtain evidence for: * Recruitment methodology effectiveness * The usefulness of the "Canestest" test as a screening tool * The time required for the vaginal microbiota (particularly Lactobacillus count) to return to normal after treatment of BV infection with metronidazole. * The time required for the Nugent Score to return to normal after treatment of BV infection with metronidazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Metronidazole | Women with Bacterial Vaginosis treated with Metronidazole for 5 days |
| OTHER | Control: no treatment | Healthy women without Bacterial Vaginosis |
Timeline
- Start date
- 2017-09-04
- Primary completion
- 2017-11-14
- Completion
- 2017-11-14
- First posted
- 2017-06-15
- Last updated
- 2017-12-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03187457. Inclusion in this directory is not an endorsement.